The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 closed down 0.38% at 7,969 points.

Energy was the best performing sector, up1%, followed by Staples, up 0.4%, and Materials, up 0.33%.

Real Estate was the biggest loser, down 2.2%, followed by IT, down 2%, and Discretionary, down 1%.

In the Green

Core Lithium (ASX:CXO) closed up 5.2% following the release of an update on its Finniss Lithium Operation.

Core Lithium closed at 8 cents.

Neuren Pharmaceuticals (ASX:NEU) finished up 0.67% on news the company is developing a new product to treat infant injuries when a baby’s brain does not receive enough oxygen or blood flow before or shortly after birth.

Neuren Pharmaceuticals finished at $12.01.

And, Reject Shop (ASX:TRS) has closed up 109% after investors flocked to the stock as the company received a takeover offer. Canada’s Dollarama (TSX:DOL) cut a deal to buy Reject Shop for $259 million.

Reject Shop closed at $6.60.

In the Red

Domain (ASX:DHG) closed down 4.9% after CoStar Group (NASDAQ:CSGP) improved its takeover offer, from $4.20 cash per share to $4.43 per share.

Domain wrapped up at $4.25.

Pro Medicus (ASX:PME) closed down 7.8% after being swept up in today’s tech sell-off. Broker Macquarie retained its “neutral” rating and its $257.40 price target.

Pro Medicus pulled up stumps at $210.00.

And, WiseTech (ASX:WTC) closed down 2% as investors reacted to Australian Super selling its entire $580M stake in the company.  AusSuper’s move came due to “governance concerns” and worries about the board.

Wisetech finished the day at $83.66.

More From The Market Online

Resolution secures two diamond core rigs for Golden Gate tungsten, gold drilling

Resolution is ramping up exploration of the historic Golden Gate project with two diamond core drill…

Red Mountain draws up exclusive option agreement for the Pioneer Tungsten Project in Montana

Red Mountain has entered an exclusive 30-day option agreement to acquire the Pioneer Tungsten Project in…

Leeuwin is expanding Marda potential with ‘extremely encouraging’ intercepts; more drilling lined up for May

Leeuwin says the latest RC drilling from the Evanston and Golden Orb deposits at the Marda…
Detail of a representation of pain in the knee with red color on a bluish image. Side view.

Paradigm Biopharma advances Phase 3 OA Trial on tail of positive DSMB safety review

Paradigm Biopharma's pivotal Phase 3 PARA_OA_012 clinical trial will "proceed as designed" after a safety review…